Non-Clear Cell Renal Cancer: Disease-Based Management and Opportunities for Targeted Therapeutic Approaches
- 1 August 2013
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 40 (4) , 511-520
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Reductive carboxylation supports growth in tumour cells with defective mitochondriaNature, 2011
- The Glycolytic Shift in Fumarate-Hydratase-Deficient Kidney Cancer Lowers AMPK Levels, Increases Anabolic Propensities and Lowers Cellular Iron LevelsCancer Cell, 2011
- Transcription Factor E3 and Transcription Factor EB Renal Cell Carcinomas: Clinical Features, Biological Behavior and Prognostic FactorsJournal of Urology, 2011
- Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinomaInvestigational New Drugs, 2010
- Targeted therapies for non-clear renal cell carcinomaTargeted Oncology, 2010
- UOK 262 cell line, fumarate hydratase deficient (FH−/FH−) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancerCancer Genetics and Cytogenetics, 2010
- Effect of Collecting Duct Histology on Renal Cell Cancer OutcomeJournal of Urology, 2009
- Hereditary kidney cancerCancer, 2009
- Association of Germline Mutations in the Fumarate Hydratase Gene and Uterine Fibroids in Women With Hereditary Leiomyomatosis and Renal Cell CancerArchives of Dermatology, 2008
- Identification and characterization of a novel folliculin-interacting protein FNIP2Gene, 2008